Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ 2,670,000	$ (18,748,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	7,181,000	7,862,000
Amortization of debt issuance costs	1,815,000	1,647,000
Amortization of interest on contract liabilities	493,000	578,000
Accrued interest on convertible notes, related party	2,904,000	2,640,000
Amortization of core premiums paid to customers	8,055,000	7,310,000
Amortization of finished goods premiums paid to customers	760,000	703,000
Noncash lease expense	7,588,000	7,265,000
Foreign exchange impact of lease liabilities and forward contracts	(10,411,000)	18,966,000
Change in fair value of compound net derivative liability	140,000	(2,460,000)
Gain on short-term investments	(283,000)	(126,000)
Net provision for inventory reserves	6,957,000	11,317,000
Net provision for customer payment discrepancies and credit losses	533,000	324,000
Deferred income taxes	(361,000)	(3,479,000)
Share-based compensation expense	4,318,000	3,009,000
Loss on disposal of plant and equipment	17,000	(6,000)
Changes in operating assets and liabilities:
Accounts receivable	10,869,000	12,475,000
Inventory	(45,087,000)	17,546,000
Prepaid expenses and other current assets	(2,791,000)	(1,000,000)
Other assets	687,000	(1,392,000)
Accounts payable and accrued liabilities	16,519,000	(22,854,000)
Customer finished goods returns accrual	3,336,000	2,637,000
Contract assets	(710,000)	(18,031,000)
Contract liabilities	14,653,000	18,300,000
Operating lease liabilities	(7,571,000)	(6,754,000)
Other liabilities	1,383,000	(1,361,000)
Net cash provided by operating activities	23,664,000	36,368,000
Cash flows from investing activities:
Purchase of plant and equipment	(2,250,000)	(1,716,000)
Proceeds for the sale of plant and equipment	0	49,000
Redemption of short-term investments	104,000	53,000
Net cash used in investing activities	(2,146,000)	(1,614,000)
Cash flows from financing activities:
Borrowings under revolving loan	554,945,000	375,461,000
Repayments of revolving loan	(557,722,000)	(408,659,000)
Payments for debt issuance costs	0	(15,000)
Payments on finance lease obligations	(1,217,000)	(1,306,000)
Exercise of stock options	101,000	0
Cash used to net share settle equity awards	(2,095,000)	(181,000)
Repurchase of common stock, including fees	(8,351,000)	(2,096,000)
Net cash used in financing activities	(14,339,000)	(36,796,000)
Effect of exchange rate changes on cash and cash equivalents	903,000	(1,122,000)
Net increase (decrease) in cash and cash equivalents	8,082,000	(3,164,000)
Cash and cash equivalents — Beginning of period	9,429,000	13,974,000
Cash and cash equivalents — End of period	17,511,000	10,810,000
Supplemental disclosures of cash flow information:
Cash paid for interest, net	31,379,000	37,845,000
Cash paid for income taxes, net of refunds	4,906,000	4,338,000
Cash paid for operating leases	10,777,000	10,183,000
Cash paid for finance leases	1,441,000	1,446,000
Plant and equipment acquired under finance leases	1,928,000	684,000
Assets acquired under operating leases	313,000	2,512,000
Accrued capital expenditures	$ 132,000	$ 144,000